Integration of genomic and nongenomic/rapid ER signaling and its... | Download Scientific Diagram
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology
Cancers | Free Full-Text | Classical and Non-Classical Progesterone Signaling in Breast Cancers | HTML
The many faces of estrogen signaling - Biochemia Medica
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Frontiers | Non-canonical Estrogen Signaling in Endocrine Resistance | Endocrinology
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Four major mechanisms of estrogen and estrogen receptors (ER). (I)... | Download Scientific Diagram
